COMMUNIQUÉS West-GlobeNewswire

Novartis data at ESC Congress 2026 reinforce cardiovascular leadership and showcase progress in next-generation therapies
19/08/2026
Late-breaking Phase IV VICTORION-CHALLENGE data will evaluate Leqvio ® (inclisiran) vs. bempedoic acid in achieving LDL-C goals New AZALEA-TIMI 71 analyses will further characterize the bleeding profile of abelacimab in [...]
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026
19/08/2026
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026 Presentation will provide additional analysis from the Phase IIa study of RESP-X in Pseudomonas aeruginosa -colonised [...]
Two physicians at The Wall Center named to America's Best Plastic Surgeons 2026 — a first for any Shreveport practice
18/08/2026
SHREVEPORT, La., Aug. 18, 2026 (GLOBE NEWSWIRE) -- The Wall Center for Plastic Surgery announced today that two of its surgeons have been named to Newsweek 's America's Best Plastic Surgeons 2026 list, ranked in [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 14, 2026 it granted stock options to purchase an aggregate of 27,565 shares of [...]
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
18/08/2026
FULLERTON, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that its board of directors has adopted resolutions approving a reverse stock [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
FOSTER CITY, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective August 17, 2026, it granted stock options to purchase [...]
Acquisition of Own Shares
18/08/2026
Mechelen, Belgium; 18 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Iridex Reports Second Quarter 2026 Financial Results
18/08/2026
MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the [...]
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
18/08/2026
Event and Webcast to be held August 20th, 2026, 9:00 AM ET MILLBRAE, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated [...]
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
18/08/2026
Follows recent European patent grant and coverage in multiple international markets as Silo continues to strengthen licensed IP portfolio for lead therapeutic program SARASOTA, FLA., Aug. 18, 2026 (GLOBE NEWSWIRE) -- [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
WALTHAM, Mass., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market
18/08/2026
Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations FullPAC (NASDAQ [...]
Immunocine Cancer Center Expands as Demand Grows for Personalized Dendritic Cell Therapy
18/08/2026
HOUSTON, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Responding to a growing number of patients seeking personalized cancer immunotherapy, Immunocine Cancer Center has opened a second treatment location in Cabo San Lucas, Mexico [...]
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
18/08/2026
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd [...]
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
18/08/2026
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026 Halle (Saale) / Munich, Germany, August 18, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon [...]
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
18/08/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available NEWPORT BEACH, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Hoag announced today [...]
Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy
18/08/2026
AKTX-101 demonstrated robust anti-tumor activity across multiple clinically relevant urothelial cancer preclinical models Data supports the potential of Akari’s novel PH1 RNA spliceosome-modulating payload to overcome [...]
BioPorto activates the first US clinical site as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
18/08/2026
August 18, 2026 Press Release BioPorto activates the first US clinical site as part of the ProNephro AKI ® U.S. Adult Urine NGAL Validation Study. COPENHAGEN, DENMARK, August 18, 2026 – BioPorto A/S (“BioPorto” or “ [...]
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
18/08/2026
Dr. Ernest Brings Significant Value-based Care and Clinical Expertise ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its [...]

Pages